Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide
H Derendorf - The Journal of Clinical Pharmacology, 2007 - Wiley Online Library
Inhaled corticosteroids are recommended first‐line therapy for persistent asthma of all
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.
H Derendorf - Journal of Clinical Pharmacology, 2007 - europepmc.org
Inhaled corticosteroids are recommended first-line therapy for persistent asthma of all
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide
H Derendorf - Journal of clinical pharmacology, 2007 - pubmed.ncbi.nlm.nih.gov
Inhaled corticosteroids are recommended first-line therapy for persistent asthma of all
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide.
H Derendorf - Journal of Clinical Pharmacology, 2007 - go.gale.com
Inhaled corticosteroids are recommended first-line therapy for persistent asthma of all
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
severities; however, oropharyngeal and systemic adverse events can be a concern. Inhaled …
[引用][C] Pharmacokinetic and Pharmacodynamic Properties of Inhaled Ciclesonide
H Derendorf - The Journal of Clinical Pharmacology, 2007 - cir.nii.ac.jp